PAK5 and hepatocellular carcinoma: In this regard, the study by Li and colleagues dissected the mechanisms downstream of the decreased expression of miR-138-1-3p in HCC and found the serine/threonine kinase PAK5 (p21 activated kinase 5) among its targets.